Advertisement

Topics

BIO.COM Company Profile

22:13 EDT 25th September 2017 | BioPortfolio

The life science research community is a uniquely vital component of our society. Those dedicated to gaining an understanding of fundamental biological processes appreciate its profundity and, along with the casual observer, are aware of its value to an improved quality of life. Bio.com exists to create a distributed, online community of scientists, professionals, businesses and organizations supporting the life sciences for the purpose of facilitating communications and disseminating information within that community. Opening channels of information can only benefit those who strive to contribute to these endeavors, and we are very pleased to have an opportunity to participate.
Bio.com is the successor to BRNI, an Internet project initiated in early 1992. At that time, the Internet was used solely for research purposes and I had no preconception that its use would become as wide-spread and general as it is today. In retrospect, it's difficult for even me to recall that we were one of only 50 websites that existed worldwide in 1992. We've watched the rise and fall of the "dot.com" boom and have proudly remained true to our cause through it all. It has been a challenge for us to grow and adapt to the rapidly changing Internet environment, and it often seems that our long-range plans change weekly. Consequently, Bio.com continues to be a work in progress-with dynamic goals and dimensions. Please utilize and judge Bio.com accordingly.

We solicit your participation. Your comments, suggestions and criticisms are invited. We are open to discussing collaborations with other organizations and motivated individuals. Oddly, despite the large number of professionals using Bio.com, we do not receive the level of feedback we desire. It amazes me how our acceptance has grown to the point that we seem to be somewhat taken for granted. Perhaps the best indication of this is the sudden response we get whenever a server goes down.

Bio.com is a commercial enterprise, owned and operated by BIO.COM. We are not funded by the government and have not requested any form of tax-exempt status. We believe that free enterprise affords us the greatest latitude to pursue our goals with the least compromise due to bureaucracies and politics. In effect, we are willing to allow our success to be based on the value we yield. And, we continue to grow as we enter our 10th year in business.

Why do we quote the Tao? It is a simple reminder that our purpose is not to change the world, but to be a part of it. To that end, we feel that we've been very successful as our participation and contributions are beyond dispute

Location

1900 Powell StreetSuite 230
Emeryville
California
94608
United States of America

Contact

Phone: (510) 601-7194
Fax: (510) 601-1862
Email: corp@bio.com


News Articles [1115483 Results]

Managed Care Firms Improperly Cut N.Y. Home Services For Disabled Medicaid Patients: Report

The detailed report by a coalition of more than 100 nonprofit groups finds hundreds of patients were affected.

A Young Woman Dies, A Teen Is Saved After Amoebas Infect The Brain

In Florida, perfect timing and alert medical staff saved a teen from almost certain death. But in North Carolina, one young woman died of an amoeba infection after rafting at a popular tourist site.

Highlights of LIVE Day 1: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017 BOSTON, MA • UNITED STATES

Highlights of LIVE Day 1: World Medical Innovation Forum – CARDIOVASCULAR • MAY 1-3, 2017  BOSTON, MA • UNITED STATES Leaders in Pharmaceutical Business Intelligence (LPBI) Group will cover...

DRÉPANOCYTOSE: La guérison possible par thérapie génique - N Engl J Med

Pour la première un patient atteint de drépanocytose est en rémission complète suite à traitement par thérapie génique. Cet essai clinique de phase I/I...

Gut bacteria could play a role in the development of diseases like Alzheimer's and Parkinson's.

Gut bacteria could play a role in the development of diseases like Alzheimer's and Parkinson's.

Impax Laboratories Receives Form 483 Following FDA Inspection

FDA issues a Form 483 following inspection of Impax Laboratories' Hayward, CA facility. read more

Beyond the Crisis

First published in 1994, this volume discusses the nature of health care reform and the capacity for medical excellence within the context of such reform.

Interferon-Inducible Protein 10 Is A Potent Inhibitor Of Angiogenesis

Human interferon inducible protein 10 (IP-10) is a member of the chemokine family of molecules. It is a secreted protein with a molecular weight of approximately 8.6 kD. Previous work has demonstrated...

Clinical Trials [126291 Results]

The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery

Arnica montana is a homeopathic drug that is made in accordance with the official methods of the Homeopathic Pharmacopoeia of the United States (HPUS) and is commonly used by cosmetic surg...

Pharyngeal Size in Patients With Obstructive Tonsils Under Orthodontic Treatment

Enlarged tonsils and malocclusion has relationship with sleep disturbance in children. The consequences of these features can include aggravation of craniofacial growth such that the devel...

The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response

The purpose of this study is to assess the effects of repeated RIPC and exercise, on exercise performance, skeletal muscle responses and circulating cellular and humoral biology in humans

Pilot Study of Raltegravir Lipodystrophy IISP

The substitution of raltegravir for the NRTIs will result in some reversal of the long term adverse effect of lipodystrophy (specifically peripheral lipoatrophy) that is associated with th...

Esophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radiation Therapy and/or Chemotherapy

Brief Summary: RATIONALE: Comparing results of diagnostic procedures, such as esophagoscopy, done before and after radiation therapy and/or chemotherapy may help doctors predict a patient...

Companies [52545 Results]

Biogen Idec Inc.

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Founded in 1978, Biogen Idec is a global leader in the discovery, development, manufa...

Compugen Ltd.

Compugen is a leading drug and diagnostic product candidate discovery company. Unlike traditional high throughput trial and error experimental based discovery, Compugen's discovery efforts are b...

Schiff Nutrition International, Inc.

Schiff Nutrition International, Inc. develops, manufactures, markets and distributes branded and private label vitamins, nutritional supplements and nutrition bars in the United S...

Fero Industries, Inc.

Fero Industries, Inc. is a publicly traded holding company (OTC BB: FROI.OB). Fero’s mission is to acquire healthcare related companies, products, and technologies that have large market poten...

Water Pik, Inc.

Water Pik is a leading developer, manufacturer and marketer of innovative personal healthcare products sold under the Waterpik® brand name. The Company has developed and introd...

More Information about "BIO.COM" on BioPortfolio

We have published hundreds of BIO.COM news stories on BioPortfolio along with dozens of BIO.COM Clinical Trials and PubMed Articles about BIO.COM for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BIO.COM Companies in our database. You can also find out about relevant BIO.COM Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biological Therapy
Biological therapy involves the use of living organisms, substances derived from living organisms, or laboratory-produced versions of such substances to treat disease. Some biological therapies for cancer use vaccines or bacteria to stimulate the body&rs...


Corporate Database Quicklinks



Searches Linking to this Company Record